Latest: FDA Approves New Biosimilar for Oncology Treatment
Healthcare Business

Biomarker Testing, Perioperative Treatment in NSCLC: Frank Weinberg, MD, PhD

by American Journal Managed Care
0 Comments
0 Mins
A panel held during the Institute for Value-Based Medicine event in Chicago on August 14, 2025, included discussions of access to biomarker testing and perioperative treatment in patients with non–small cell lung cancer (NSCLC).
Tags:
American Journal Managed Care
Author

American Journal Managed Care

Previous Post
Schrödinger Halts CDC7 Inhibitor After Two Patient Deaths
Next Post
ARC and Revealense Collaborate on Joint Venture to Deliver At-Home AI-Based Neurological Diagnostics
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago